CRISPR-CasΦ from huge phages is a hypercompact genome editor

Patrick Pausch(Innovative Genomics Institute), Basem Al-Shayeb(Innovative Genomics Institute), Ezra Bisom-Rapp(University of California, Berkeley), Connor A. Tsuchida(University of California, San Francisco), Zheng Li(University of California, Los Angeles), Brady F. Cress(Innovative Genomics Institute), Gavin J. Knott(Discovery Institute), Steven E. Jacobsen(Howard Hughes Medical Institute), Jillian F. Banfield(Planetary Science Institute), Jennifer A. Doudna(Gladstone Institutes)
Science
July 17, 2020
Cited by 551Open Access
Full Text

Abstract

CRISPR-Cas systems are found widely in prokaryotes, where they provide adaptive immunity against virus infection and plasmid transformation. We describe a minimal functional CRISPR-Cas system, comprising a single ~70-kilodalton protein, CasΦ, and a CRISPR array, encoded exclusively in the genomes of huge bacteriophages. CasΦ uses a single active site for both CRISPR RNA (crRNA) processing and crRNA-guided DNA cutting to target foreign nucleic acids. This hypercompact system is active in vitro and in human and plant cells with expanded target recognition capabilities relative to other CRISPR-Cas proteins. Useful for genome editing and DNA detection but with a molecular weight half that of Cas9 and Cas12a genome-editing enzymes, CasΦ offers advantages for cellular delivery that expand the genome editing toolbox.


Related Papers